Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Sulopenem Etzadroxil/Probenecid.

Hospital pharmacy·2025

Same author

Axatilimab.

Hospital pharmacy·2025

Same author

Respiratory Syncytial Virus Vaccine (mRNA).

Hospital pharmacy·2024

Same author

Resmetirom.

Hospital pharmacy·2024

Same author

Cefepime/Enmetazobactam.

Hospital pharmacy·2024

Same author

Capivasertib.

Hospital pharmacy·2024

Same journal

Stability of Diluted Intravenous Metronidazole in 0.9% Sodium Chloride.

Hospital pharmacy·2026

Same journal

Response to Comment on "Early Versus Later Anticoagulation After Ischemic Stroke in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials".

Hospital pharmacy·2026

Same journal

Significant Published Articles in 2025 for Pharmacy Nutrition Support Practice.

Hospital pharmacy·2026

Same journal

Comment on "Early Versus Later Anticoagulation After Ischemic Stroke in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials".

Hospital pharmacy·2026

Same journal

Comparison of Cystatin C-Based and Serum Creatinine-Based Renal Function Estimates Against Timed Urine Collection in Critically Ill Patients.

Hospital pharmacy·2026

Same journal

Comment on "Pharmacy Physiotherapy Interprofessional Education and Practice".

Hospital pharmacy·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 12, 2025

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on: September 25, 2018

Lecanemab.

Terri L Levien¹, Danial E Baker¹

¹Washington State University, Spokane, WA, USA.

Hospital Pharmacy

|September 25, 2024

Summary

This summary is machine-generated.

The Formulary Monograph Service provides monthly drug monographs for Pharmacy & Therapeutics Committees, aiding in informed drug evaluation and utilization. Subscribers receive comprehensive reviews and customizable resources for pharmacy and nursing staff.

Keywords:

drug information formulary management/P & T neurology

More Related Videos

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Related Experiment Videos

Last Updated: Jun 12, 2025

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on: September 25, 2018

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Area of Science:

Pharmacology
Drug Information Services
Health-System Pharmacy

Background:

Pharmacy & Therapeutics (P&T) Committees require timely and accurate drug information.
Evaluating new and investigational drugs is crucial for formulary management.
Effective drug utilization reviews (DURs) and medication use evaluations (MUEs) are essential for patient safety and cost-effectiveness.

Purpose of the Study:

To introduce The Formulary Monograph Service as a resource for P&T Committees.
To highlight the service's provision of detailed monographs on new and late-phase trial drugs.
To inform about supplementary resources like summary monographs and DUE/MUEs.

Main Methods:

The service delivers 5-6 detailed monographs monthly on drugs in early release or Phase III trials.
One-page summary monographs are provided for pharmacy and nursing in-service needs.
Comprehensive drug utilization evaluation/medication use evaluation (DUE/MUE) reports are included.

Main Results:

Subscribers gain access to well-documented drug information.
Resources are tailored for P&T Committee agendas and staff education.
Online access and customization options enhance usability for healthcare facilities.

Conclusions:

The Formulary Monograph Service supports evidence-based formulary decisions.
It facilitates efficient drug evaluation and medication use monitoring.
The service enhances pharmacy practice through accessible, relevant drug information.